AGI House memo: foundation models enter the "structure to function" phase in drug discovery
agihouse_org · x · 2026-09-07
AGI House published a memo, "From Structure to Function: The Next Phase of Foundation Models in Drug Discovery," on the current state of foundation models in drug discovery.
Where traditional computational approaches relied on physics-based simulations or task-specific models trained on narrow datasets, foundation models offer large-scale pretraining on biological data followed by adaptation to downstream tasks. The memo examines the technical characteristics distinguishing domain-specific from general-purpose models, the bottlenecks constraining practical utility, and the directions believed most promising.
More from Research
- Three diffusion papers head to ECCV: Flash-BoN, PFM and dynamic image-gen benchmarks — RisingSayak · 2026-09-07
- MIT PhD defense on physics-constrained generative design, with Kaiming He on committee — Scobleizer · 2026-09-07
- Doppio: TU Darmstadt dataset trains vision models to weigh falling coffee grounds contactless — rsasaki0109 · 2026-09-07
- OR-Clarify benchmarks asking clarifying questions before optimization modeling — AIOR-Research · 2026-09-07
- How keyword spotting models power "Hey Siri": a detailed technical guide — cneuralnetwork · 2026-09-07
- Reward hacking stems from bad reward modeling and eval awareness, developer argues — secemp9 · 2026-09-07